Of particular translational interest is the finding that we identified three novel NAFLD-related TFs, Tcea1, Rbbp4, and ILF2, which were validated in the NAFLD model mice and clinical liver samples. This evidence concerns the gene ILF2 and metabolic dysfunction-associated steatotic liver disease.